Carbon Nanotubes—Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
Authors:
- Camilla Kofoed AndersenCACamilla Kofoed Andersen
- Sangita KhatriSKSangita Khatri
- Jonas HansenJHJonas Hansen
- Sofie SlottSSSofie Slott
- Rohith Pavan ParvathaneniRPRohith Pavan Parvathaneni
- Ana C. MendesAMAna C. Mendes
- Ioannis S. ChronakisIoannis S. Chronakis
- Shu-Chen HungSHShu-Chen Hung
- Narendiran RajasekaranNRNarendiran Rajasekaran
- Zhuoran MaZMZhuoran Ma
- Shoujun ZhuSZShoujun Zhu
- Hongjie DaiHDHongjie Dai
Open Access
- 27 March 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (4) , 453
Abstract
Two types of single-walled carbon nanotubes (SWCNTs), HiPco- and carboxyl-SWCNT, are evaluated as drug carriers for the traditional anti-inflammatory drug methotrexate (MTX) and a small interfering RNA (siRNA) targeting NOTCH1 gene. The nanotubes are solubilized by PEGylation and covalently loaded with MTX. The coupling efficiency (CE%) of MTX is 77–79% for HiPco-SWCNT and 71–83% for carboxyl-SWCNT. siRNA is noncovalently attached to the nanotubes with efficiency of 90–97% for HiPco-SWCNT and 87–98% for carboxyl-SWCNT. Through whole body imaging in the second near-infrared window (NIR-II window, 1000–1700 nm), SWCNTs were found to be selectively accumulated in inflamed joints in a serum transfer mouse model. We further investigated the interactions of the siRNA/MTX loaded nanotubes with human blood and mice bone marrow cells. In human blood, both types of unloaded SWCNTs were associated with B cells, monocytes and neutrophils. Interestingly, loading with MTX suppressed SWCNTs targeting specificity to immune cells, especially B cells; in contrast, loading siRNA alone enhanced the targeting specificity. Loading both MTX and siRNA to carboxyl-SWCNT enhanced targeting specificity to neutrophils and monocytes but not B cells. The targeting specificity of SWCNTs can potentially be adjusted by altering the ratio of MTX and siRNA loaded. The combined results show that carbon nanotubes have the potential for delivery of cargo drugs specifically to immune cells involved in rheumatoid arthritis.Keywords
Funding Information
- Villum Fonden (41093)
- Innovationsfonden (7076- 00053B)
This publication has 51 references indexed in Scilit:
- Synthesis and characterization of multi-walled carbon nanotubes modified with octadecylamine and polyethylene glycolArabian Journal of Chemistry, 2017
- PEGylated Single-Walled Carbon Nanotubes as Nanocarriers for Cyclosporin A DeliveryAAPS PharmSciTech, 2013
- A Locked Nucleic Acid-Based Nanocrawler: Designed and Reversible Movement Detected by Multicolor FluorescenceJournal of the American Chemical Society, 2013
- LNA for Optimization of Fluorescent Oligonucleotide Probes: Improved Spectral Properties and Target BindingBioconjugate Chemistry, 2011
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RAAnnals of the Rheumatic Diseases, 2010
- Enhanced anticancer activity of multi-walled carbon nanotube–methotrexate conjugates using cleavable linkersChemical Communications, 2009
- A route to brightly fluorescent carbon nanotubes for near-infrared imaging in miceNature Nanotechnology, 2009
- Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug deliveryNano Research, 2009
- Immunohistological localization of Notch receptors and their ligands Delta and Jagged in synovial tissues of rheumatoid arthritisJournal of Orthopaedic Science, 2005
- Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblastsOncogene, 2003